Cargando…

Development and Validation of a Nomogram Incorporating Colloid Osmotic Pressure for Predicting Mortality in Critically Ill Neurological Patients

Backgrounds: The plasma colloid osmotic pressure (COP) values for predicting mortality are not well-estimated. A user-friendly nomogram could predict mortality by incorporating clinical factors and scoring systems to facilitate physicians modify decision-making when caring for patients with serious...

Descripción completa

Detalles Bibliográficos
Autores principales: Lv, Bo, Hu, Linhui, Fang, Heng, Sun, Dayong, Hou, Yating, Deng, Jia, Zhang, Huidan, Xu, Jing, He, Linling, Liang, Yufan, Chen, Chunbo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8740271/
https://www.ncbi.nlm.nih.gov/pubmed/35004737
http://dx.doi.org/10.3389/fmed.2021.765818
_version_ 1784629277879173120
author Lv, Bo
Hu, Linhui
Fang, Heng
Sun, Dayong
Hou, Yating
Deng, Jia
Zhang, Huidan
Xu, Jing
He, Linling
Liang, Yufan
Chen, Chunbo
author_facet Lv, Bo
Hu, Linhui
Fang, Heng
Sun, Dayong
Hou, Yating
Deng, Jia
Zhang, Huidan
Xu, Jing
He, Linling
Liang, Yufan
Chen, Chunbo
author_sort Lv, Bo
collection PubMed
description Backgrounds: The plasma colloid osmotic pressure (COP) values for predicting mortality are not well-estimated. A user-friendly nomogram could predict mortality by incorporating clinical factors and scoring systems to facilitate physicians modify decision-making when caring for patients with serious neurological conditions. Methods: Patients were prospectively recruited from March 2017 to September 2018 from a tertiary hospital to establish the development cohort for the internal test of the nomogram, while patients recruited from October 2018 to June 2019 from another tertiary hospital prospectively constituted the validation cohort for the external validation of the nomogram. A multivariate logistic regression analysis was performed in the development cohort using a backward stepwise method to determine the best-fit model for the nomogram. The nomogram was subsequently validated in an independent external validation cohort for discrimination and calibration. A decision-curve analysis was also performed to evaluate the net benefit of the insertion decision using the nomogram. Results: A total of 280 patients were enrolled in the development cohort, of whom 42 (15.0%) died, whereas 237 patients were enrolled in the validation cohort, of which 43 (18.1%) died. COP, neurological pathogenesis and Acute Physiology and Chronic Health Evaluation II (APACHE II) score were predictors in the prediction nomogram. The derived cohort demonstrated good discriminative ability, and the area under the receiver operating characteristic curve (AUC) was 0.895 [95% confidence interval (CI), 0.840–0.951], showing good correction ability. The application of this nomogram to the validation cohort also provided good discrimination, with an AUC of 0.934 (95% CI, 0.892–0.976) and good calibration. The decision-curve analysis of this nomogram showed a better net benefit. Conclusions : A prediction nomogram incorporating COP, neurological pathogenesis and APACHE II score could be convenient in predicting mortality for critically ill neurological patients.
format Online
Article
Text
id pubmed-8740271
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-87402712022-01-08 Development and Validation of a Nomogram Incorporating Colloid Osmotic Pressure for Predicting Mortality in Critically Ill Neurological Patients Lv, Bo Hu, Linhui Fang, Heng Sun, Dayong Hou, Yating Deng, Jia Zhang, Huidan Xu, Jing He, Linling Liang, Yufan Chen, Chunbo Front Med (Lausanne) Medicine Backgrounds: The plasma colloid osmotic pressure (COP) values for predicting mortality are not well-estimated. A user-friendly nomogram could predict mortality by incorporating clinical factors and scoring systems to facilitate physicians modify decision-making when caring for patients with serious neurological conditions. Methods: Patients were prospectively recruited from March 2017 to September 2018 from a tertiary hospital to establish the development cohort for the internal test of the nomogram, while patients recruited from October 2018 to June 2019 from another tertiary hospital prospectively constituted the validation cohort for the external validation of the nomogram. A multivariate logistic regression analysis was performed in the development cohort using a backward stepwise method to determine the best-fit model for the nomogram. The nomogram was subsequently validated in an independent external validation cohort for discrimination and calibration. A decision-curve analysis was also performed to evaluate the net benefit of the insertion decision using the nomogram. Results: A total of 280 patients were enrolled in the development cohort, of whom 42 (15.0%) died, whereas 237 patients were enrolled in the validation cohort, of which 43 (18.1%) died. COP, neurological pathogenesis and Acute Physiology and Chronic Health Evaluation II (APACHE II) score were predictors in the prediction nomogram. The derived cohort demonstrated good discriminative ability, and the area under the receiver operating characteristic curve (AUC) was 0.895 [95% confidence interval (CI), 0.840–0.951], showing good correction ability. The application of this nomogram to the validation cohort also provided good discrimination, with an AUC of 0.934 (95% CI, 0.892–0.976) and good calibration. The decision-curve analysis of this nomogram showed a better net benefit. Conclusions : A prediction nomogram incorporating COP, neurological pathogenesis and APACHE II score could be convenient in predicting mortality for critically ill neurological patients. Frontiers Media S.A. 2021-12-24 /pmc/articles/PMC8740271/ /pubmed/35004737 http://dx.doi.org/10.3389/fmed.2021.765818 Text en Copyright © 2021 Lv, Hu, Fang, Sun, Hou, Deng, Zhang, Xu, He, Liang and Chen. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Medicine
Lv, Bo
Hu, Linhui
Fang, Heng
Sun, Dayong
Hou, Yating
Deng, Jia
Zhang, Huidan
Xu, Jing
He, Linling
Liang, Yufan
Chen, Chunbo
Development and Validation of a Nomogram Incorporating Colloid Osmotic Pressure for Predicting Mortality in Critically Ill Neurological Patients
title Development and Validation of a Nomogram Incorporating Colloid Osmotic Pressure for Predicting Mortality in Critically Ill Neurological Patients
title_full Development and Validation of a Nomogram Incorporating Colloid Osmotic Pressure for Predicting Mortality in Critically Ill Neurological Patients
title_fullStr Development and Validation of a Nomogram Incorporating Colloid Osmotic Pressure for Predicting Mortality in Critically Ill Neurological Patients
title_full_unstemmed Development and Validation of a Nomogram Incorporating Colloid Osmotic Pressure for Predicting Mortality in Critically Ill Neurological Patients
title_short Development and Validation of a Nomogram Incorporating Colloid Osmotic Pressure for Predicting Mortality in Critically Ill Neurological Patients
title_sort development and validation of a nomogram incorporating colloid osmotic pressure for predicting mortality in critically ill neurological patients
topic Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8740271/
https://www.ncbi.nlm.nih.gov/pubmed/35004737
http://dx.doi.org/10.3389/fmed.2021.765818
work_keys_str_mv AT lvbo developmentandvalidationofanomogramincorporatingcolloidosmoticpressureforpredictingmortalityincriticallyillneurologicalpatients
AT hulinhui developmentandvalidationofanomogramincorporatingcolloidosmoticpressureforpredictingmortalityincriticallyillneurologicalpatients
AT fangheng developmentandvalidationofanomogramincorporatingcolloidosmoticpressureforpredictingmortalityincriticallyillneurologicalpatients
AT sundayong developmentandvalidationofanomogramincorporatingcolloidosmoticpressureforpredictingmortalityincriticallyillneurologicalpatients
AT houyating developmentandvalidationofanomogramincorporatingcolloidosmoticpressureforpredictingmortalityincriticallyillneurologicalpatients
AT dengjia developmentandvalidationofanomogramincorporatingcolloidosmoticpressureforpredictingmortalityincriticallyillneurologicalpatients
AT zhanghuidan developmentandvalidationofanomogramincorporatingcolloidosmoticpressureforpredictingmortalityincriticallyillneurologicalpatients
AT xujing developmentandvalidationofanomogramincorporatingcolloidosmoticpressureforpredictingmortalityincriticallyillneurologicalpatients
AT helinling developmentandvalidationofanomogramincorporatingcolloidosmoticpressureforpredictingmortalityincriticallyillneurologicalpatients
AT liangyufan developmentandvalidationofanomogramincorporatingcolloidosmoticpressureforpredictingmortalityincriticallyillneurologicalpatients
AT chenchunbo developmentandvalidationofanomogramincorporatingcolloidosmoticpressureforpredictingmortalityincriticallyillneurologicalpatients